It has been reported that Rgnef protein expression was significantly increased in patients with late-stage serous ovarian cancer and high Rgnef levels were associated with decreased progression-free and overall survival of these patients. The gene discussed is ARHGEF28; the disease is ovarian serous adenocarcinoma.